Roth Capital Downgrades Uroplasty To Neutral
Roth Capital has downgraded Uroplasty (NASDAQ: UPI) from Buy to Neutral.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Roth CapitalDowngrades Analyst Ratings